Abstract
ObjectiveTo evaluate long-term clinical, functional and radiographic outcomes in an open-label extension (OLE) study in patients with rheumatoid arthritis (RA) receiving adalimumab monotherapy or adalimumab+methotrexate following attainment of low disease...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have